+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asthma Drugs Market Research Reports

From
From
From
IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Asthma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Asthma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Asthma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 152 Pages
  • Global
From
CINQAIR Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

CINQAIR Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
From
Montelukast Sodium Market 2024-2028 - Product Thumbnail Image

Montelukast Sodium Market 2024-2028

  • Report
  • October 2024
  • 140 Pages
  • Global
From
From
Severe Asthma: Eight-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Severe Asthma: Eight-Market Drug Forecast and Market Analysis

  • Report
  • February 2025
  • 135 Pages
  • Global
From
Caffeine Gummies - Global Strategic Business Report - Product Thumbnail Image

Caffeine Gummies - Global Strategic Business Report

  • Report
  • August 2025
  • 142 Pages
  • Global
From
Eosinophilic Asthma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Eosinophilic Asthma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Asthma and Severe Asthma: Epidemiology Forecast to 2033 - Product Thumbnail Image

Asthma and Severe Asthma: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 70 Pages
  • Global
From
Loading Indicator

The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers. Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more